Literature DB >> 9266

Clinical effect of L-dopa on schizophrenia.

C Ogura, A Kishimoto, T Nakao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 9266

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  4 in total

1.  Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.

Authors:  R J Hardie; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

Review 2.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

Review 3.  A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications.

Authors:  George E Jaskiw; Anand P Popli
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

4.  Partial improvement in negative schizophrenic symptoms after amphetamine.

Authors:  B Angrist; E Peselow; M Rubinstein; J Corwin; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.